|
1
|
Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
|
Hepatology
|
1996
|
1.89
|
|
2
|
Allograft rejection after liver transplantation for autoimmune liver diseases.
|
Liver Transpl Surg
|
1998
|
1.53
|
|
3
|
MicroRNAs as immune regulators: implications for transplantation.
|
Am J Transplant
|
2010
|
1.16
|
|
4
|
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.
|
Transplantation
|
1995
|
1.13
|
|
5
|
Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines.
|
J Immunol
|
1997
|
1.12
|
|
6
|
Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis.
|
J Exp Med
|
1995
|
1.11
|
|
7
|
Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis.
|
Hepatology
|
1995
|
0.99
|
|
8
|
Differential expression of microRNAs during allograft rejection.
|
Am J Transplant
|
2012
|
0.98
|
|
9
|
Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation.
|
Radiology
|
2000
|
0.97
|
|
10
|
Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients.
|
Transplant Proc
|
1995
|
0.96
|
|
11
|
Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils.
|
Transplantation
|
1993
|
0.91
|
|
12
|
Apoptosis and allograft rejection in the absence of CD8+ T cells.
|
Transplantation
|
2001
|
0.90
|
|
13
|
Molecular definitions, autoepitopes, and enzymatic activities of the mitochondrial autoantigens of primary biliary cirrhosis.
|
Semin Liver Dis
|
1989
|
0.90
|
|
14
|
Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway.
|
J Immunol
|
2001
|
0.90
|
|
15
|
Expression of cytokines and immune mediators during chronic liver allograft rejection.
|
Transplantation
|
1995
|
0.89
|
|
16
|
Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis.
|
Liver
|
2001
|
0.88
|
|
17
|
Intragraft cytokine profile during human liver allograft rejection.
|
Transplantation
|
1992
|
0.88
|
|
18
|
Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection.
|
Transplantation
|
1995
|
0.88
|
|
19
|
Characterization of allograft rejection in an experimental model of small intestinal transplantation.
|
J Gastrointest Surg
|
1999
|
0.87
|
|
20
|
Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma.
|
Am J Transplant
|
2009
|
0.85
|
|
21
|
Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients.
|
Transplantation
|
1995
|
0.85
|
|
22
|
Acute liver allograft rejection in the rat. An analysis of the immune response.
|
Transplantation
|
1995
|
0.84
|
|
23
|
CD30 expression identifies a functional alloreactive human T-lymphocyte subset.
|
Transplantation
|
1998
|
0.81
|
|
24
|
PI3Kδ inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomas.
|
Am J Transplant
|
2013
|
0.81
|
|
25
|
IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro.
|
Transplantation
|
1993
|
0.79
|
|
26
|
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.
|
Transplantation
|
1998
|
0.79
|
|
27
|
Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients.
|
Liver Transpl
|
2000
|
0.78
|
|
28
|
Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder.
|
Am J Transplant
|
2013
|
0.78
|
|
29
|
Interleukin-12: a possible cytotoxic T-lymphocyte differentiation factor in allograft recipients.
|
Transplant Proc
|
1995
|
0.78
|
|
30
|
Cytokines are involved in the rejection of small intestine allografts.
|
Transplant Proc
|
1997
|
0.77
|
|
31
|
EBV B lymphoma cell lines from patients with post-transplant lymphoproliferative disease are resistant to TRAIL-induced apoptosis.
|
Am J Transplant
|
2006
|
0.77
|
|
32
|
Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts.
|
Transplantation
|
1996
|
0.77
|
|
33
|
Involvement of Fas-Fas ligand interactions in graft rejection.
|
Int Rev Immunol
|
1999
|
0.76
|
|
34
|
Acute rejection of small intestine allografts is associated with increased expression of toll-like receptors.
|
Transplant Proc
|
2010
|
0.75
|
|
35
|
Circulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in pediatric liver recipients.
|
Transplant Proc
|
1995
|
0.75
|
|
36
|
Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection.
|
Transplant Proc
|
1993
|
0.75
|
|
37
|
Elevated biliary interleukin 5 as an indicator of liver allograft rejection.
|
Transpl Immunol
|
1995
|
0.75
|
|
38
|
Characterization of cytokine expression in an animal model of acute liver allograft rejection.
|
Transplant Proc
|
1995
|
0.75
|
|
39
|
Long-term nonresponsiveness to a liver allograft may be cytokine mediated.
|
Transplant Proc
|
1995
|
0.75
|
|
40
|
T cell receptor usage by cytotoxic T lymphocytes against autologous human melanoma.
|
Anticancer Res
|
1997
|
0.75
|
|
41
|
Distinct patterns of Th2 cytokine production during immune activation in pediatric liver allograft recipients.
|
Transplant Proc
|
1995
|
0.75
|